Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2811 Wilshire Blvd
Santa Monica, CA 90403Phone+1 310-829-9788
Education & Training
- Tufts Medical CenterResidency, Radiology-Diagnostic, 1998 - 2002
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 1997 - 1998
- NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 1996 - 1997
- New York Medical CollegeClass of 1996
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Musculoskeletal Imaging
Certifications & Licensure
- MA State Medical License 1997 - 2026
- CA State Medical License 2003 - 2025
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsFurther optimisation of a macromolecular ocular irritation test (OptiSafe).Stewart Lebrun, Sara Chavez, Linda Nguyen, Roxanne Chan
Cutaneous and Ocular Toxicology. 2023-03-01 - 2 citationsExpansion of the application domain of a macromolecular ocular irritation test (OptiSafe™).Stewart Lebrun, Sara Chavez, Linda Nguyen, Roxanne Chan
Toxicology in Vitro. 2023-02-01 - 3 citationsAscorbic acid specifically reduces the misclassification of nonirritating reactive chemicals in the OptiSafe™ macromolecular eye irritation test.Stewart Lebrun, Sara Chavez, Roxanne Chan, Linda Nguyen, James V Jester
Toxicology in Vitro. 2022-04-01
Journal Articles
- Further Optimization of a Macromolecular Ocular Irritation Test (OptiSafeTM)Stewart Lebrun, Sara Chavez, Linda Nguyen & Roxanne Chan, Cutaneous and Ocular Toxicology, 1/20/2023
Grant Support
- R44 IVD EIT a Nonanimal Kit and Service for the Detection of Ocular Irritants: Phase IINational Institutes of Health2023–2026
- 1R44 An In Chemical Test to Identify Dermal CorrosivesNIH2024–2025
- R21 Antioxidant Eye Wash Formulations to Counter Ocular Chemical ThreatsNIH2023–2025
Research History
- Non-Animal TestingToxicology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: